A Non-pharmacological Cough Control Therapy (NCT04767074)
A Non-pharmacological Cough Control Therapy as an Adjuvant of Pulmonary Rehabilitation in People With Interstitial Lung Diseases and Chronic Cough - A Feasibility Study
🩺 Plain-English Summary (8th-Grade Level)
Coughing affects almost all individuals with ILD leading to physical, psychological and social distress and prevents individuals from performing their activities of daily living, working or socialising in public places. Unfortunately, there are no licensed medications available to treat chronic cough and the few drugs that have been tried resulted in little efficacy and significant side effects. Drug-free cough control interventions have shown promise in reducing the severity and impact of coughing on patients' lives but have not been tested in individuals with ILD. This study aims to explore the feasibility and effectiveness of a non-pharmacological cough control therapy, as an adjuvant of pulmonary rehabilitation, in patients with ILD and chronic cough (\>8 weeks in duration).
Who can join: Review the eligibility criteria below.
Location: St. Joseph's Healthcare Hamilton — Hamilton, Ontario
Age range: 18 Years to 85 Years
🧪 Interventions in This Study
- Non-pharmacological Cough control Therapy (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- St. Joseph's Healthcare Hamilton — Hamilton, Ontario
- West Park Healthcare Centre — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (647) 765-1525
Email: ana.oliveira@westpark.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cough
- A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough — Foley, Alabama
- A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough — Calgary, Alberta
- Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures — New York, New York
- Stimulation of the Larynx to Treat Unexplained Chronic Cough — Minneapolis, Minnesota
- Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough — Birmingham, Alabama
Explore by condition: All Cough clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.